Prosecution Insights
Last updated: August 18, 2026

Examiner: DEVEAU ROSEN, JASON

Tech Center 1600 • Art Units: 1638 1662

This examiner grants 80% of resolved cases

Performance Statistics

80.1%
Allow Rate
+20.1% vs TC avg
866
Total Applications
+16.4%
Interview Lift
918
Avg Prosecution Days
Based on 834 resolved cases, 2023–2026

Rejection Statute Breakdown

3.0%
§101 Eligibility
13.9%
§102 Novelty
24.9%
§103 Obviousness
45.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19421128 PROCESS FOR THE PRODUCTION OF CLOSED LINEAR DNA Non-Final OA TYRIS THERAPEUTICS, S.L.
17432559 SUPPRESSION OF TARGET GENE EXPRESSION THROUGH GENOME EDITING OF NATIVE MIRNAS Final Rejection SYNGENTA CROP PROTECTION AG
19131469 A SPINACH PLANT RESISTANT TO DOWNY MILDEW AND A RESISTANCE GENE Non-Final OA ENZA ZADEN BEHEER B.V.
18654512 LETTUCE VARIETIES ‘E01C11866’, ‘E01L30616’ AND ‘E01B11959’ Non-Final OA Enza Zaden Beheer B.V.
19071964 TARGETED MUTAGENESIS OF TOBACCO BERBERINE BRIDGE ENZYME-LIKE NUCLEIC ACIDS Non-Final OA North Carolina State University

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month